Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
6
|
Zenith Epigenetics
|
Feb 03, 2019 04:01AM
|
Re: Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
|
6
|
Resverlogix Corp.
|
Jan 11, 2018 01:23PM
|
Re: ZEN-3694 Single Agent Trial Status
|
6
|
Zenith Epigenetics
|
Sep 18, 2017 11:17PM
|
Re: An ESC video from youtube that mentions Apabetalone, posted July 10 2019
|
6
|
Resverlogix Corp.
|
Sep 10, 2019 02:40PM
|
Re: No news
|
6
|
Resverlogix Corp.
|
Sep 16, 2022 04:29PM
|
Re: The MD@A for the period ending July 31, 2017
|
6
|
Resverlogix Corp.
|
Sep 19, 2017 12:26AM
|
Re: ORI Debenture
|
6
|
Resverlogix Corp.
|
Oct 04, 2019 02:21PM
|
Re: Wow talk about saying....
|
6
|
Resverlogix Corp.
|
Nov 01, 2019 02:02AM
|
Re: Prostate Trial
|
6
|
Zenith Epigenetics
|
Apr 24, 2020 10:50AM
|
Just one thought
|
6
|
Resverlogix Corp.
|
Nov 01, 2019 02:53AM
|
Re: RVXs up or down draft from ZENE???
|
6
|
Resverlogix Corp.
|
Jan 10, 2024 02:59PM
|
Re: Corona- COVID-19
|
6
|
Resverlogix Corp.
|
Mar 05, 2020 08:16PM
|
Election Day
|
6
|
Resverlogix Corp.
|
Nov 03, 2020 12:04PM
|
Happy New Year
|
6
|
Resverlogix Corp.
|
Jan 01, 2019 03:51AM
|
Re: The flipside of negative
|
6
|
Resverlogix Corp.
|
Sep 22, 2021 02:04AM
|
Re: so what happens if dm fumbles the ball??
|
6
|
Resverlogix Corp.
|
Jul 12, 2020 01:30AM
|
Re: ZEN-3694 Single Agent Trial Status
|
6
|
Zenith Epigenetics
|
Sep 21, 2017 03:57AM
|
Re: BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency
|
6
|
Resverlogix Corp.
|
Dec 05, 2017 06:42PM
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
6
|
Resverlogix Corp.
|
Mar 25, 2022 03:15PM
|
Thank you for your civility
|
6
|
Resverlogix Corp.
|
Dec 01, 2019 12:01AM
|